This is a table of adjective/noun combinations and their frequencies from sentences in your study carrel. Use it to search & browse the list to learn more about your study carrel.
adjective | noun | frequency |
---|---|---|
- | cov-2 | 23780 |
- | cov | 9642 |
respiratory | syndrome | 3508 |
novel | coronavirus | 2071 |
covid-19 | patients | 1249 |
immune | response | 823 |
- | sars | 707 |
viral | rna | 623 |
- | cell | 562 |
immune | responses | 522 |
human | coronavirus | 462 |
viral | infection | 453 |
- | coronavirus | 374 |
covid-19 | infection | 361 |
human | ace2 | 353 |
new | coronavirus | 349 |
viral | infections | 322 |
- | protein | 318 |
respiratory | disease | 316 |
humans | . | 293 |
- | analysis | 272 |
human | transmission | 259 |
antiviral | drugs | 225 |
covid-19 | cases | 209 |
severe | disease | 207 |
covid-19 | . | 206 |
inflammatory | response | 194 |
- | infection | 185 |
respiratory | viruses | 178 |
immune | cells | 171 |
clinical | studies | 167 |
severe | cases | 166 |
severe | covid-19 | 159 |
viral | proteins | 158 |
respiratory | infections | 145 |
antiviral | drug | 141 |
clinical | samples | 112 |
human | sars | 109 |
human | cells | 108 |
specific | antibodies | 106 |
first | case | 104 |
available | . | 103 |
inflammatory | responses | 98 |
respiratory | infection | 92 |
positive | patients | 90 |
several | studies | 88 |
human | cases | 84 |
other | viruses | 82 |
other | studies | 82 |
viral | transmission | 81 |
severe | sars | 81 |
respiratory | virus | 79 |
negative | . | 77 |
covid-19 | patient | 76 |
viral | protein | 76 |
positive | . | 71 |
positive | sars | 71 |
covid-19 | vaccine | 70 |
respiratory | samples | 66 |
clinical | study | 64 |
- | virus | 64 |
- | ace2 | 63 |
novel | sars | 63 |
specific | antibody | 63 |
- | cells | 63 |
human | infection | 61 |
potential | drug | 61 |
novel | virus | 60 |
potential | treatment | 60 |
respiratory | diseases | 60 |
covid-19 | disease | 59 |
human | mers | 59 |
potential | drugs | 58 |
- | receptor | 58 |
viral | diseases | 56 |
positive | samples | 55 |
- | mers | 54 |
other | coronavirus | 53 |
others | . | 52 |
positive | cases | 50 |
human | cell | 47 |
respiratory | coronavirus | 47 |
new | virus | 46 |
first | cases | 45 |
inflammatory | syndrome | 45 |
severe | patients | 44 |
covid-19 | treatment | 43 |
new | drugs | 42 |
other | drugs | 42 |
other | rna | 42 |
therapeutic | drugs | 42 |
- | drug | 41 |
severe | coronavirus | 41 |
covid-19 | infections | 40 |
potential | vaccine | 40 |
other | sars | 39 |
human | disease | 39 |
antiviral | treatment | 39 |
human | proteins | 38 |
antiviral | response | 37 |
inflammatory | cells | 37 |
therapeutics | . | 37 |
early | transmission | 36 |
covid-19 | transmission | 35 |
different | sars | 34 |
inflammatory | diseases | 34 |
immune | cell | 33 |
severe | infection | 32 |
low | . | 32 |
covid-19 | vaccines | 32 |
clinical | disease | 31 |
human | receptor | 31 |
first | covid-19 | 30 |
new | drug | 30 |
- | patient | 29 |
- | treatment | 29 |
new | cases | 28 |
potential | . | 28 |
inflammatory | drugs | 28 |
human | antibody | 28 |
human | antibodies | 27 |
important | . | 27 |
first | sars | 27 |
positive | cells | 26 |
- | antibody | 26 |
specific | treatment | 26 |
specific | cell | 26 |
such | patients | 26 |
human | . | 26 |
different | cell | 26 |
acute | sars | 26 |
specific | sars | 26 |
- | case | 25 |
- | rna | 25 |
human | infections | 25 |
- | infections | 23 |
first | patient | 23 |
other | patients | 23 |
viral | disease | 23 |
clinical | treatment | 22 |
potential | transmission | 22 |
novel | viruses | 22 |
available | sars | 22 |
available | drugs | 22 |
antiviral | responses | 22 |
potential | sars | 21 |
potential | vaccines | 21 |
acute | infection | 21 |
positive | antibody | 21 |
early | infection | 21 |
- | patients | 20 |
first | study | 20 |
other | proteins | 20 |
severe | infections | 20 |
- | analyses | 19 |
human | patients | 19 |
negative | samples | 19 |
new | sars | 19 |
viral | receptor | 19 |
several | vaccine | 18 |
different | viruses | 18 |
human | diseases | 18 |
different | samples | 17 |
earlier | studies | 17 |
other | . | 17 |
other | diseases | 17 |
several | cases | 17 |
several | sars | 16 |
other | cells | 16 |
inflammatory | protein | 16 |
new | vaccine | 16 |
clinical | analysis | 16 |
clinical | case | 16 |
- | response | 16 |
antivirals | . | 16 |
other | samples | 15 |
potential | treatments | 15 |
other | vaccines | 15 |
therapeutic | treatment | 15 |
human | protein | 15 |
covid-19 | drug | 15 |
clinical | cases | 15 |
early | treatment | 14 |
higher | case | 14 |
human | samples | 14 |
human | viruses | 14 |
new | disease | 14 |
specific | vaccines | 14 |
therapeutic | antibodies | 13 |
such | antibodies | 13 |
several | viruses | 13 |
viral | drugs | 13 |
severe | diseases | 13 |
negative | sars | 13 |
higher | transmission | 13 |
higher | antibody | 13 |
high | case | 13 |
different | studies | 13 |
inflammatory | cell | 13 |
different | coronavirus | 13 |
potential | covid-19 | 12 |
several | drugs | 12 |
viral | receptors | 12 |
therapeutic | drug | 12 |
other | cell | 12 |
other | study | 12 |
high | sars | 12 |
high | antibody | 12 |
different | virus | 12 |
several | patients | 11 |
specific | proteins | 11 |
specific | drugs | 11 |
high | . | 11 |
specific | rna | 11 |
positive | patient | 11 |
potential | mers | 11 |
- | proteins | 11 |
other | virus | 11 |
other | infections | 11 |
human | studies | 11 |
higher | ace2 | 11 |
- | vaccine | 11 |
other | drug | 10 |
such | cases | 10 |
respiratory | sample | 10 |
viral | drug | 10 |
such | studies | 10 |
early | sars | 10 |
novel | covid-19 | 10 |
severe | mers | 10 |
earlier | . | 10 |
different | . | 10 |
covid-19 | drugs | 10 |
- | receptors | 10 |
clinical | response | 10 |
antiviral | treatments | 10 |
acute | disease | 10 |
different | patients | 10 |
human | cov | 9 |
viral | vaccines | 9 |
viral | cell | 9 |
other | mers | 9 |
novel | drugs | 9 |
new | treatment | 9 |
human | virus | 9 |
human | covid-19 | 9 |
severe | case | 9 |
high | transmission | 9 |
early | cases | 9 |
different | vaccines | 9 |
different | mers | 9 |
covid-19 | virus | 9 |
acute | covid-19 | 9 |
- | transmission | 9 |
high | ace2 | 9 |
new | infections | 8 |
specific | vaccine | 8 |
specific | receptor | 8 |
respiratory | sars | 8 |
other | cases | 8 |
new | viruses | 8 |
new | vaccines | 8 |
human | vaccine | 8 |
negative | patients | 8 |
higher | sars | 8 |
high | virus | 8 |
first | coronavirus | 8 |
earlier | study | 8 |
clinical | sars | 8 |
acute | mers | 8 |
negative | cases | 7 |
new | rna | 7 |
other | disease | 7 |
respiratory | cells | 7 |
positives | . | 7 |
severe | . | 7 |
several | vaccines | 7 |
specific | . | 7 |
such | drugs | 7 |
human | vaccines | 7 |
low | antibody | 7 |
new | case | 7 |
human | transmissions | 7 |
covid-19 | case | 7 |
higher | virus | 7 |
acute | infections | 7 |
antiviral | proteins | 7 |
clinical | sample | 7 |
antiviral | protein | 7 |
different | proteins | 7 |
different | vaccine | 7 |
early | studies | 7 |
- | study | 7 |
higher | infection | 7 |
several | cell | 6 |
other | treatments | 6 |
positive | covid-19 | 6 |
positive | rna | 6 |
potential | infection | 6 |
respiratory | syndromes | 6 |
respiratory | transmission | 6 |
several | case | 6 |
viral | responses | 6 |
specific | drug | 6 |
specific | responses | 6 |
specific | virus | 6 |
such | vaccines | 6 |
therapeutic | antibody | 6 |
other | receptors | 6 |
viral | sars | 6 |
other | treatment | 6 |
other | vaccine | 6 |
other | protein | 6 |
first | drug | 6 |
novel | vaccine | 6 |
available | case | 6 |
different | patient | 6 |
early | disease | 6 |
early | response | 6 |
early | study | 6 |
first | antibody | 6 |
antiviral | vaccines | 6 |
higher | . | 6 |
lower | sars | 6 |
lower | virus | 6 |
new | covid-19 | 6 |
new | diseases | 6 |
novel | drug | 6 |
inflammatory | treatments | 6 |
positive | sample | 5 |
lower | . | 5 |
lower | case | 5 |
new | infection | 5 |
new | study | 5 |
novel | disease | 5 |
other | antibodies | 5 |
positive | case | 5 |
specific | receptors | 5 |
potential | receptor | 5 |
several | virus | 5 |
specific | mers | 5 |
such | cells | 5 |
such | study | 5 |
viral | response | 5 |
viral | treatment | 5 |
inflammatory | drug | 5 |
low | sars | 5 |
- | covid-19 | 5 |
immune | receptors | 5 |
different | disease | 5 |
- | disease | 5 |
- | sample | 5 |
- | studied | 5 |
humans | sars | 5 |
covid-19 | antibody | 5 |
covid-19 | coronavirus | 5 |
different | cells | 5 |
antiviral | . | 5 |
different | protein | 5 |
first | studies | 5 |
high | infection | 5 |
human | receptors | 5 |
human | response | 5 |
human | responses | 5 |
human | rna | 5 |
early | case | 5 |
potential | antibody | 4 |
several | mers | 4 |
respiratory | rna | 4 |
potential | disease | 4 |
other | covid-19 | 4 |
positive | responses | 4 |
positive | mers | 4 |
other | infection | 4 |
several | proteins | 4 |
several | protein | 4 |
other | ace2 | 4 |
specific | cells | 4 |
specific | disease | 4 |
specific | infection | 4 |
such | antibody | 4 |
such | viruses | 4 |
therapeutic | studies | 4 |
therapeutic | treatments | 4 |
therapeutic | vaccines | 4 |
viral | samples | 4 |
viral | vaccine | 4 |
other | antibody | 4 |
- | antibodies | 4 |
novel | treatment | 4 |
different | receptors | 4 |
new | studies | 4 |
- | vaccines | 4 |
anti | sars | 4 |
antiviral | antibodies | 4 |
available | antibodies | 4 |
available | vaccine | 4 |
clinical | syndromes | 4 |
covid-19 | samples | 4 |
covid-19 | treatments | 4 |
available | studies | 4 |
different | treatment | 4 |
first | antibodies | 4 |
high | protein | 4 |
high | vaccine | 4 |
human | patient | 4 |
inflammatory | proteins | 4 |
negative | antibody | 4 |
negative | patient | 4 |
new | cells | 4 |
early | covid-19 | 4 |
other | transmission | 3 |
potential | virus | 3 |
potential | receptors | 3 |
potential | patients | 3 |
positive | virus | 3 |
positive | infection | 3 |
new | syndrome | 3 |
other | case | 3 |
novel | receptor | 3 |
novel | diseases | 3 |
new | treatments | 3 |
several | samples | 3 |
several | diseases | 3 |
therapeutic | proteins | 3 |
specific | ace2 | 3 |
specific | case | 3 |
specific | patient | 3 |
specific | treatments | 3 |
such | analyses | 3 |
such | drug | 3 |
such | infections | 3 |
such | samples | 3 |
such | treatment | 3 |
therapeutic | . | 3 |
negative | case | 3 |
viral | syndrome | 3 |
new | mers | 3 |
potential | coronavirus | 3 |
low | virus | 3 |
first | infection | 3 |
low | ace2 | 3 |
- | drugs | 3 |
acute | cases | 3 |
antiviral | vaccine | 3 |
available | samples | 3 |
clinical | treatments | 3 |
earlier | sars | 3 |
earlier | virus | 3 |
earliest | . | 3 |
early | drug | 3 |
early | virus | 3 |
first | . | 3 |
available | vaccines | 3 |
first | vaccine | 3 |
human | case | 3 |
inflammatory | syndromes | 3 |
first | vaccines | 3 |
inflammatory | disease | 3 |
important | drugs | 3 |
immune | studies | 3 |
important | drug | 3 |
highest | sars | 3 |
highest | ace2 | 3 |
higher | disease | 3 |
higher | covid-19 | 3 |
novel | vaccines | 2 |
new | patients | 2 |
other | analyses | 2 |
novel | treatments | 2 |
novel | syndrome | 2 |
novel | rna | 2 |
novel | protein | 2 |
novel | cell | 2 |
newer | vaccines | 2 |
lower | ace2 | 2 |
new | cell | 2 |
lower | vaccine | 2 |
lower | responses | 2 |
lower | antibody | 2 |
low | mers | 2 |
low | disease | 2 |
inflammatory | treatment | 2 |
potential | studies | 2 |
inflammatory | . | 2 |
positive | response | 2 |
such | transmission | 2 |
respiratory | . | 2 |
such | case | 2 |
important | protein | 2 |
viral | treatments | 2 |
viral | studies | 2 |
viral | antibody | 2 |
viral | antibodies | 2 |
therapeutic | study | 2 |
such | vaccine | 2 |
such | disease | 2 |
such | . | 2 |
several | coronavirus | 2 |
specific | study | 2 |
specific | response | 2 |
specific | protein | 2 |
specific | coronavirus | 2 |
specific | analysis | 2 |
severe | virus | 2 |
several | rna | 2 |
several | drug | 2 |
important | vaccine | 2 |
low | sample | 2 |
immune | receptor | 2 |
different | infections | 2 |
different | case | 2 |
different | antibodies | 2 |
covid-19 | covid-19 | 2 |
covid-19 | antibodies | 2 |
clinical | syndrome | 2 |
clinical | mers | 2 |
clinical | infection | 2 |
available | virus | 2 |
available | treatment | 2 |
available | mers | 2 |
available | drug | 2 |
antiviral | studies | 2 |
antiviral | diseases | 2 |
antiviral | coronavirus | 2 |
acute | treatment | 2 |
acute | diseases | 2 |
- | viruses | 2 |
- | samples | 2 |
immune | diseases | 2 |
different | cases | 2 |
clinical | drug | 2 |
different | rna | 2 |
first | proteins | 2 |
different | sample | 2 |
higher | vaccine | 2 |
higher | rna | 2 |
higher | response | 2 |
higher | cell | 2 |
high | disease | 2 |
high | % | 2 |
first | sample | 2 |
high | patient | 2 |
human | study | 2 |
earlier | treatment | 2 |
first | infections | 2 |
different | transmission | 2 |
different | treatments | 2 |
different | study | 2 |
earliest | cases | 2 |
earliest | studies | 2 |
highest | mers | 2 |
newer | infections | 1 |
novel | proteins | 1 |
newer | studies | 1 |
novel | . | 1 |
novel | antibody | 1 |
novel | case | 1 |
novel | infection | 1 |
novel | infections | 1 |
novel | mers | 1 |
positive | cell | 1 |
novel | studies | 1 |
novel | study | 1 |
other | patient | 1 |
other | receptor | 1 |
other | studied | 1 |
other | syndrome | 1 |
other | syndromes | 1 |
positive | ace2 | 1 |
positive | studies | 1 |
new | analysis | 1 |
new | receptor | 1 |
low | vaccine | 1 |
new | analyses | 1 |
new | ace2 | 1 |
low | rna | 1 |
potential | analysis | 1 |
lower | antibodies | 1 |
lower | cell | 1 |
lower | covid-19 | 1 |
lower | disease | 1 |
lower | infection | 1 |
lower | mers | 1 |
lower | sample | 1 |
lowest | mers | 1 |
lowest | sars | 1 |
negative | antibodies | 1 |
negative | covid-19 | 1 |
negative | mers | 1 |
negative | rna | 1 |
negative | studies | 1 |
negative | virus | 1 |
negatives | . | 1 |
new | . | 1 |
positive | study | 1 |
specific | covid-19 | 1 |
potential | antibodies | 1 |
potential | cases | 1 |
specific | studies | 1 |
such | ace2 | 1 |
such | analysis | 1 |
such | cell | 1 |
such | diseases | 1 |
such | infection | 1 |
such | protein | 1 |
such | proteins | 1 |
such | treatments | 1 |
such | virus | 1 |
therapeutic | cases | 1 |
therapeutic | covid-19 | 1 |
therapeutic | protein | 1 |
therapeutic | vaccine | 1 |
therapeutics | drugs | 1 |
therapeutics | receptor | 1 |
viral | analysis | 1 |
viral | sample | 1 |
low | protein | 1 |
specific | samples | 1 |
specific | sample | 1 |
specific | infections | 1 |
several | al | 1 |
potential | protein | 1 |
potential | sample | 1 |
respiratory | drug | 1 |
respiratory | drugs | 1 |
respiratory | patient | 1 |
respiratory | receptors | 1 |
respiratory | response | 1 |
respiratory | treatments | 1 |
several | antibodies | 1 |
specific | diseases | 1 |
several | antibody | 1 |
several | cells | 1 |
several | covid-19 | 1 |
several | infections | 1 |
several | receptors | 1 |
several | treatment | 1 |
severe | patient | 1 |
severer | disease | 1 |
low | response | 1 |
anti | coronavirus | 1 |
low | patient | 1 |
covid-19 | proteins | 1 |
covid-19 | study | 1 |
different | ace2 | 1 |
different | analyses | 1 |
different | covid-19 | 1 |
different | diseases | 1 |
different | drug | 1 |
different | drugs | 1 |
different | response | 1 |
different | responses | 1 |
earlier | case | 1 |
earlier | cases | 1 |
earlier | infection | 1 |
earliest | antibody | 1 |
earliest | case | 1 |
earliest | sars | 1 |
early | . | 1 |
early | antibody | 1 |
early | infections | 1 |
early | patients | 1 |
covid-19 | response | 1 |
clinical | vaccine | 1 |
low | infection | 1 |
clinical | responses | 1 |
- | cases | 1 |
- | diseases | 1 |
- | sampled | 1 |
acute | . | 1 |
acute | coronavirus | 1 |
acute | patients | 1 |
acute | response | 1 |
acute | virus | 1 |
antiviral | antibody | 1 |
antiviral | cell | 1 |
antiviral | sars | 1 |
antivirals | drugs | 1 |
antivirals | sars | 1 |
available | patient | 1 |
available | receptors | 1 |
available | rna | 1 |
available | treatments | 1 |
clinical | drugs | 1 |
clinical | patients | 1 |
first | analysis | 1 |
first | cells | 1 |
first | disease | 1 |
first | drugs | 1 |
immune | disease | 1 |
immune | patients | 1 |
immune | sars | 1 |
important | cell | 1 |
important | cells | 1 |
important | coronavirus | 1 |
important | infection | 1 |
important | mers | 1 |
important | proteins | 1 |
important | receptor | 1 |
important | syndromes | 1 |
important | transmission | 1 |
important | treatment | 1 |
important | treatments | 1 |
inflammatory | antibody | 1 |
inflammatory | infections | 1 |
low | case | 1 |
low | cell | 1 |
low | covid-19 | 1 |
immune | . | 1 |
humans | virus | 1 |
humans | transmission | 1 |
high | rna | 1 |
first | patients | 1 |
first | protein | 1 |
first | rna | 1 |
first | sampled | 1 |
first | syndrome | 1 |
high | cell | 1 |
high | mers | 1 |
high | receptor | 1 |
high | treatment | 1 |
humans | patient | 1 |
higher | antibodies | 1 |
higher | mers | 1 |
higher | receptor | 1 |
highest | . | 1 |
highest | infection | 1 |
highest | virus | 1 |
human | drug | 1 |
human | sample | 1 |
viral | syndromes | 1 |